Nguyen, Minh Tuan
1607  results:
Search for persons X
?
 
?
4

Performance of the 2019 ESC/EASD guideline strategy for the..:

Valensi, Paul ; Berkane, Narimane ; Pinto, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-01760-4.  , 2023
 
?
 
?
6

Performance of the 2019 ESC/EASD guideline strategy for the..:

Valensi, Paul ; Berkane, Narimane ; Pinto, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-01760-4.  , 2023
 
?
7

Performance of the 2019 ESC/EASD guideline strategy for the..:

Valensi, Paul ; Berkane, Narimane ; Pinto, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-01760-4.  , 2023
 
?
8

Performance of the 2019 ESC/EASD guideline strategy for the..:

Valensi, Paul ; Berkane, Narimane ; Pinto, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-01760-4.  , 2023
 
?
9

Transition practice for primary immunodeficiency diseases i..:

Chee Mun Chan ; Amir Hamzah Abdul Latiff ; Lokman Mohd Noh...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1209315/full.  , 2023
 
?
 
?
12

Performance of the 2019 ESC/EASD guideline strategy for the..:

Valensi, Paul ; Berkane, Narimane ; Pinto, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12933-023-01760-4.  , 2023
 
1-15